See also this year's filing and all EDGAR filings for this company.
PDF Report 0000944809_2019_OPKO_Health_INC.pdf
Logs
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 1.1670234182138233, 'aggregate_val': 1122737000, 'exp_sum': 518101000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 358346000, 'ResearchAndDevelopmentExpense': 125586000, 'remainder_Expenses': 34169000}} |
| warning | Large missing amount for aggregate "Expenses" added to remainder. | industry.us_generic | {'missing_ratio': 0.9376329715361068, 'aggregate_val': 1183047000, 'exp_sum': 610563000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 343305000, 'ResearchAndDevelopmentExpense': 117870000, 'remainder_Expenses': 149388000}} |
Graph
Absolute values for 0000944809, OPKO Health INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 317,731,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,314,645,000 |
| 2 | PropertyPlantAndEquipmentNet | 144,674,000 |
| 3 | remainder_Assets | 674,022,000 |
| 4 | LiabilitiesCurrent | 288,321,000 |
| 5 | LiabilitiesNoncurrent | 371,460,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 240,948,999 |
| 9 | ResearchAndDevelopmentExpense | 126,598,630 |
| 10 | remainder_Expenses | 639,476,532 |
| 11 | remainder_Revenues | 962,480,586 |
| 12 | remainder_NetIncome | -17,982,244 |
| 13 | remainder_ComprehensiveNetIncome | 26,240,414 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,451,072,000 |
| 1 | Liabilities | 659,781,000 |
| 2 | Expenses | 1,007,024,161 |
| 3 | Revenues | 962,480,586 |
| 4 | StockholdersEquity | 1,791,291,000 |
| 5 | NetIncome | -62,525,819 |
| 6 | ComprehensiveNetIncome | -49,405,612 |
| 7 | BaseVar | 2,562,290,202 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.48 |
| 9 | EconomicCapitalRatio | 3.34 |